Safety and Efficacy of Oral Brivaracetam versus Levetiracetam as Monotherapy in Children Aged 1 Month to 14 Years with Newly Diagnosed Epilepsy. Pjmcr [Internet]. 2025 Jun. 30 [cited 2026 May 17];4(2):876-83. Available from: http://pakjmcr.com/index.php/1/article/view/450